- Home
- TGHL vs EVGN Comparison
TGHL vs EVGN Comparison
Compare TGHL & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TGHL | EVGN |
|---|---|---|
| Founded | 2020 | 1999 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Agricultural Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 9.1M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | TGHL | EVGN |
|---|---|---|
| Price | $0.31 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 05-01-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $94,130.00 | ★ $8,016,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.19 |
| 52 Week Low | $0.29 | $0.91 |
| 52 Week High | $4.25 | $2.42 |
Technical Indicators
Market Signals| Indicator | TGHL | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 42.48 | 40.08 |
| Support Level | $0.30 | $0.91 |
| Resistance Level | $0.36 | $1.19 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 2.44 | 15.15 |
Price Performance
Historical ComparisonAbout TGHL The GrowHub Limited Class A Ordinary Shares
The Growhub Ltd operates at the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, It has developed a multi-faceted approach to address industry challenges. its business currently comprises two main divisions, which are the GrowHub Platform and its product trading facilitation offering.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.